These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 3920973)
1. [Phase II study of UFT in cancer of the uterine cervix]. Noda K; Teshima K; Ikeda M; Sugawa T; Yamagata S; Sekiba K; Kohno I; Kaneshige E; Sawaragi I; Matsuoka I Gan To Kagaku Ryoho; 1985 Apr; 12(4):900-6. PubMed ID: 3920973 [TBL] [Abstract][Full Text] [Related]
2. [Phase II study of 5-FU tablets in cancer of the uterine cervix]. Sekiba K; Yajima A; Tenjin Y; Kurihara S; Akiya K; Okada K; Noda K; Ozaki M; Hasegawa K; Mori T Gan To Kagaku Ryoho; 1987 Jul; 14(7):2365-73. PubMed ID: 3606156 [TBL] [Abstract][Full Text] [Related]
3. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT]. Suzuki M; Sekiguchi I; Ohwada M; Tamada T Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435 [TBL] [Abstract][Full Text] [Related]
4. [A phase II study of UFT in non-small cell lung cancer]. Shimizu E; Kimura K; Sone S; Inoue I; Nakamura Y; Noda Y; Hojo F; Yagi M; Nakanishi S; Yamasaki K Gan To Kagaku Ryoho; 1986 Oct; 13(10):2970-3. PubMed ID: 3021068 [TBL] [Abstract][Full Text] [Related]
5. [Report on nationwide pooled data and cohort investigation in UFT phase II study]. Ota K; Taguchi T; Kimura K Gan To Kagaku Ryoho; 1987 Sep; 14(9):2749-57. PubMed ID: 3115185 [TBL] [Abstract][Full Text] [Related]
6. [Differing progress patterns in cancer of the uterine cervix and variant effects of adjuvant chemotherapy based on histological type]. Sugawa T; Yamagata S Gan To Kagaku Ryoho; 1986 Feb; 13(2):210-5. PubMed ID: 3080962 [TBL] [Abstract][Full Text] [Related]
7. [Clinical results of UFT granule of enteric coating (UFT E granule). Osaka UFT E Granule Study Group]. Taguchi T Gan To Kagaku Ryoho; 1990 Jul; 17(7):1295-301. PubMed ID: 2114825 [TBL] [Abstract][Full Text] [Related]
8. [Clinical study of UFT in renal cell carcinoma]. Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T Gan To Kagaku Ryoho; 1985 Feb; 12(2):325-30. PubMed ID: 3918508 [TBL] [Abstract][Full Text] [Related]
9. [Phase II study of UFT for head and neck cancer]. Inuyama Y; Takeda C; Miyake H; Fujii M; Tanaka J; Hirokawa T; Ooyama W; Horiuchi M; Uchida M; Kaneko S Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):479-84. PubMed ID: 3923939 [TBL] [Abstract][Full Text] [Related]
10. [A case of uterine cervical cancer in which UFT was an effective preoperative treatment]. Nagai N; Oshita T; Shigemasa K; Ohama K; Takehara K; Miyaoka S Gan To Kagaku Ryoho; 1999 Nov; 26(13):2095-9. PubMed ID: 10584579 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study of UFT chemotherapy in renal cancer. Kyushu University Cooperative Study Group of Renal Cancer]. Ueda T; Kumazawa J; Ohmori A; Sakamoto K; Aito K; Morita I; Ohta Y; Takesue T; Hara S; Sagiyama K Gan To Kagaku Ryoho; 1990 Feb; 17(2):239-43. PubMed ID: 2105698 [TBL] [Abstract][Full Text] [Related]
12. [Maintenance chemotherapy using UFT and FT for gynecological malignant tumors. The Gunma Prefectural Society for Study of Chemotherapy for Gynecological Cancer]. Ohwada N; Nagayama M; Kosuge T; Tsukagoshi T; Ibuki Y; Igarashi M; Yazaki K; Ito T; Nogami Y; Kimura H Gan To Kagaku Ryoho; 1992 Nov; 19(13):2219-26. PubMed ID: 1444488 [TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy with cisplatin and daily administration of UFT for unresectable non-small cell lung cancer]. Takanashi N; Hara N; Ichinose Y; Asoh H; Yano T; Yokoyama H; Miura T; Matsuoka Y; Tayama K; Ohta M Gan To Kagaku Ryoho; 1993 May; 20(7):921-7. PubMed ID: 8387761 [TBL] [Abstract][Full Text] [Related]
14. Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer. Gemma A; Kudoh S; Yoshimura A; Ono Y; Takenaka K; Hayashihara K; Hino M; Shibuya M; Niitani H Anticancer Res; 1995; 15(6B):2691-5. PubMed ID: 8669849 [TBL] [Abstract][Full Text] [Related]
15. [Clinical effect of combined chemotherapy with UFT, MMC and OK-432 in recurring or advanced cancer of the digestive organs]. Aoki Y; Tabuse Y; Tanimura H; Katsumi M; Asae M; Ichimiya G; Imai T; Ooshima K; Kakihara M; Kashitani M Gan To Kagaku Ryoho; 1989 Feb; 16(2):225-34. PubMed ID: 2493222 [TBL] [Abstract][Full Text] [Related]
16. [Clinical trial of UFT in malignancies--an analysis of 337 patients. Co-operative Group for Clinical Study of UFT]. Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):373-6. PubMed ID: 3105987 [TBL] [Abstract][Full Text] [Related]
17. [Clinical effect of UFT on prostatic cancer]. Naito K; Hisazumi H; Misaki T; Shimada K; Miyazaki K; Kosaka S; Miyagi T Gan To Kagaku Ryoho; 1985 Jul; 12(7):1440-4. PubMed ID: 3925886 [TBL] [Abstract][Full Text] [Related]
18. [Comparative pharmacokinetic study between UFT and FT-207 suppo and phase II studies in gynecological malignancies]. Hatae M; Terahara M; Hokanishi H Gan To Kagaku Ryoho; 1984 Nov; 11(11):2386-92. PubMed ID: 6437345 [TBL] [Abstract][Full Text] [Related]
19. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy. Kastritis E; Bamias A; Efstathiou E; Gika D; Bozas G; Zorzou P; Sarris K; Papadimitriou C; Dimopoulos MA Gynecol Oncol; 2005 Nov; 99(2):376-82. PubMed ID: 16051322 [TBL] [Abstract][Full Text] [Related]
20. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer. Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]